Sunshine Biopharma, Inc.
SBFM
$2.18
$0.041.87%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.04M | -5.98M | -5.99M | -6.31M | -5.03M |
| Total Depreciation and Amortization | 344.20K | 332.10K | 298.90K | 267.30K | 245.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.76M | 1.76M | 1.62M | 1.06M | 0.00 |
| Change in Net Operating Assets | -1.75M | -1.43M | -3.02M | -2.75M | -6.25M |
| Cash from Operations | -5.69M | -5.31M | -7.10M | -7.73M | -11.03M |
| Capital Expenditure | -172.10K | -174.50K | -278.10K | -787.10K | -1.60M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 10.30K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -592.70K | -697.80K | -652.00K | -685.10K | 79.00K |
| Cash from Investing | -764.80K | -872.30K | -919.90K | -1.47M | -1.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 17.10K | 17.10K | 17.10K | -200.00 | 29.60K |
| Issuance of Common Stock | 4.39M | 4.75M | 5.64M | 7.54M | 3.87M |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.41M | 4.77M | 5.66M | 7.54M | 3.90M |
| Foreign Exchange rate Adjustments | 832.30K | 855.80K | -538.10K | 462.50K | -651.10K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -1.21M | -563.20K | -2.90M | -1.20M | -9.31M |